Literature DB >> 6633676

Formation of deaminated metabolites of dopamine in noradrenaline neurons.

N E Andén, M Grabowska-Andén.   

Abstract

The deaminated monoamine metabolites 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were determined electrochemically following organic solvent extraction and reverse-phase, high performance, liquid chromatography in four regions of the mouse brain. In the noradrenaline (NA)-predominant regions (hemispheres, brain stem), the ratio of the concentrations of DOPAC plus HVA to NA plus dopamine (DA) was approximately the same as in the DA-predominant regions (corpus striatum, limbic system). Yohimbine and reserpine elevated the concentrations of DOPAC and HVA both in the NA- and the DA-predominant regions. The effect of yohimbine was somewhat enhanced by the alpha 1-receptor blocking agent prazosin in the NA-predominant regions. The concentration of MOPEG was increased by yohimbine and decreased by reserpine. The concentrations of DOPAC and HVA were lowered by clonidine, but not by apomorphine in the NA-predominant regions of reserpine-treated mice. In the DA-predominant regions, apomorphine, but not clonidine, reduced the concentrations of DOPAC and HVA. The effects of clonidine and apomorphine were reversed by yohimbine and haloperidol, respectively. The results indicate that the concentrations of the acid DA metabolites DOPAC and HVA in the NA-predominant regions reflect the rate of synthesis of DA in the NA neurons.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6633676     DOI: 10.1007/BF00647830

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure.

Authors:  N E Andén; C Gomes; B Persson; G Trolin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

2.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

3.  Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain.

Authors:  T Persson; B Waldeck
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

4.  Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography.

Authors:  L J Felice; J D Felice; P T Kissinger
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

5.  The effect of reserpine upon the synthesis of norepinephrine in the isolated rabbit heart.

Authors:  C O Rutledge; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1967-08       Impact factor: 4.030

6.  Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

7.  Selective blockade of brain alpha 2-autoreceptors by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine.

Authors:  N E Andén; K Pauksens; K Svensson
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

8.  A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue.

Authors:  D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1963-02

9.  Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain.

Authors:  N Andén; M Grabowska
Journal:  Eur J Pharmacol       Date:  1976-10       Impact factor: 4.432

10.  Studies on the metabolism of catecholamines in the central nervous system of the mouse.

Authors:  P M Ceasar; P Hague; D F Sharman; B Werdinius
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

View more
  5 in total

1.  Altered in vivo catecholamine release in the hypothalamic paraventricular nucleus of the aged rat.

Authors:  J A Hastings; J M Pavia; M J Morris
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

Review 2.  A new approach to biochemical evaluation of brain dopamine metabolism.

Authors:  I J Kopin; J H White; K Bankiewicz
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

3.  Peripheral distribution of free dopamine and its metabolites in the rat.

Authors:  R Favre; M de Haut; Y Dalmaz; J M Pequignot; L Peyrin
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

4.  Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo.

Authors:  R Tao; S Hjorth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

5.  Association between learning and cortical catecholamines in non-drug-treated rats.

Authors:  B J Sahakian; G S Sarna; B D Kantamaneni; A Jackson; P H Hutson; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.